These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

109 related items for PubMed ID: 9341699

  • 1. 1H-MRS differentiates white matter hyperintensities in subcortical arteriosclerotic encephalopathy from those in normal elderly.
    Brooks WM, Wesley MH, Kodituwakku PW, Garry PJ, Rosenberg GA.
    Stroke; 1997 Oct; 28(10):1940-3. PubMed ID: 9341699
    [Abstract] [Full Text] [Related]

  • 2. Altered white and gray matter metabolism in CADASIL: a proton MR spectroscopy and 1H-MRSI study.
    Auer DP, Schirmer T, Heidenreich JO, Herzog J, Pütz B, Dichgans M.
    Neurology; 2001 Mar 13; 56(5):635-42. PubMed ID: 11245716
    [Abstract] [Full Text] [Related]

  • 3. Regional gray and white matter metabolite differences in subjects with AD, with subcortical ischemic vascular dementia, and elderly controls with 1H magnetic resonance spectroscopic imaging.
    MacKay S, Meyerhoff DJ, Constans JM, Norman D, Fein G, Weiner MW.
    Arch Neurol; 1996 Feb 13; 53(2):167-74. PubMed ID: 8639067
    [Abstract] [Full Text] [Related]

  • 4. Changes in DWI and MRS associated with white matter hyperintensities in elderly subjects.
    Firbank MJ, Minett T, O'Brien JT.
    Neurology; 2003 Oct 14; 61(7):950-4. PubMed ID: 14557566
    [Abstract] [Full Text] [Related]

  • 5. Proton magnetic resonance spectroscopy of human brain: applications to normal white matter, chronic infarction, and MRI white matter signal hyperintensities.
    Sappey-Marinier D, Calabrese G, Hetherington HP, Fisher SN, Deicken R, Van Dyke C, Fein G, Weiner MW.
    Magn Reson Med; 1992 Aug 14; 26(2):313-27. PubMed ID: 1513253
    [Abstract] [Full Text] [Related]

  • 6. Reduction in temporal N-acetylaspartate and creatine (or choline) ratio in temporal lobe epilepsy: does this 1H-magnetic resonance spectroscopy finding mean poor seizure control?
    Mendes-Ribeiro JA, Soares R, Simões-Ribeiro F, Guimarães ML.
    J Neurol Neurosurg Psychiatry; 1998 Oct 14; 65(4):518-22. PubMed ID: 9771777
    [Abstract] [Full Text] [Related]

  • 7. Evaluation of early cerebral metabolic, perfusion and microstructural changes in HCV-positive patients: a pilot study.
    Bladowska J, Zimny A, Knysz B, Małyszczak K, Kołtowska A, Szewczyk P, Gąsiorowski J, Furdal M, Sąsiadek MJ.
    J Hepatol; 2013 Oct 14; 59(4):651-7. PubMed ID: 23680314
    [Abstract] [Full Text] [Related]

  • 8. Whole-brain proton MR spectroscopic imaging in Parkinson's disease.
    Levin BE, Katzen HL, Maudsley A, Post J, Myerson C, Govind V, Nahab F, Scanlon B, Mittel A.
    J Neuroimaging; 2014 Oct 14; 24(1):39-44. PubMed ID: 23228009
    [Abstract] [Full Text] [Related]

  • 9. Longitudinal changes during aging using proton magnetic resonance spectroscopy.
    Ross AJ, Sachdev PS, Wen W, Brodaty H.
    J Gerontol A Biol Sci Med Sci; 2006 Mar 14; 61(3):291-8. PubMed ID: 16567380
    [Abstract] [Full Text] [Related]

  • 10. Reproducibility of 1H-MRS in vivo.
    Brooks WM, Friedman SD, Stidley CA.
    Magn Reson Med; 1999 Jan 14; 41(1):193-7. PubMed ID: 10025629
    [Abstract] [Full Text] [Related]

  • 11. Relative metabolite concentrations and ratios determined by use of 3-T region-specific proton magnetic resonance spectroscopy of the brain of healthy Beagles.
    Warrington CD, Feeney DA, Ober CP, Jessen CR, Steward SM, Armién AG, Fletcher TF.
    Am J Vet Res; 2013 Oct 14; 74(10):1291-303. PubMed ID: 24066913
    [Abstract] [Full Text] [Related]

  • 12. Elevated subcortical choline metabolites in cognitively and clinically asymptomatic HIV+ patients.
    Meyerhoff DJ, Bloomer C, Cardenas V, Norman D, Weiner MW, Fein G.
    Neurology; 1999 Mar 23; 52(5):995-1003. PubMed ID: 10102419
    [Abstract] [Full Text] [Related]

  • 13. MRI white matter hyperintensities, (1)H-MR spectroscopy and cognitive function in geriatric depression: a comparison of early- and late-onset cases.
    Murata T, Kimura H, Omori M, Kado H, Kosaka H, Iidaka T, Itoh H, Wada Y.
    Int J Geriatr Psychiatry; 2001 Dec 23; 16(12):1129-35. PubMed ID: 11748771
    [Abstract] [Full Text] [Related]

  • 14. Proton MR spectroscopy and white matter hyperintensities in idiopathic normal pressure hydrocephalus and other dementias.
    Algin O, Hakyemez B, Parlak M.
    Br J Radiol; 2010 Sep 23; 83(993):747-52. PubMed ID: 20647518
    [Abstract] [Full Text] [Related]

  • 15. Biochemical alterations in multiple sclerosis lesions and normal-appearing white matter detected by in vivo 31P and 1H spectroscopic imaging.
    Husted CA, Goodin DS, Hugg JW, Maudsley AA, Tsuruda JS, de Bie SH, Fein G, Matson GB, Weiner MW.
    Ann Neurol; 1994 Aug 23; 36(2):157-65. PubMed ID: 8053651
    [Abstract] [Full Text] [Related]

  • 16. 1H MR spectroscopy of gray and white matter in carbon monoxide poisoning.
    Kondziella D, Danielsen ER, Hansen K, Thomsen C, Jansen EC, Arlien-Soeborg P.
    J Neurol; 2009 Jun 23; 256(6):970-9. PubMed ID: 19252780
    [Abstract] [Full Text] [Related]

  • 17. Proton magnetic resonance spectroscopy reveals similar white matter biochemical changes in patients with chronic hypertension and early Alzheimer's disease.
    Catani M, Mecocci P, Tarducci R, Howard R, Pelliccioli GP, Mariani E, Metastasio A, Benedetti C, Senin U, Cherubini A.
    J Am Geriatr Soc; 2002 Oct 23; 50(10):1707-10. PubMed ID: 12366626
    [Abstract] [Full Text] [Related]

  • 18. Relapsing-remitting multiple sclerosis: metabolic abnormality in nonenhancing lesions and normal-appearing white matter at MR imaging: initial experience.
    He J, Inglese M, Li BS, Babb JS, Grossman RI, Gonen O.
    Radiology; 2005 Jan 23; 234(1):211-7. PubMed ID: 15528260
    [Abstract] [Full Text] [Related]

  • 19. Metabolic changes in normal-appearing white matter in patients with neuromyelitis optica and multiple sclerosis: a comparative magnetic resonance spectroscopy study.
    Duan Y, Liu Z, Liu Y, Huang J, Ren Z, Sun Z, Chen H, Dong H, Ye J, Li K.
    Acta Radiol; 2017 Sep 23; 58(9):1132-1137. PubMed ID: 28173728
    [Abstract] [Full Text] [Related]

  • 20. Is magnetic resonance spectroscopy capable of detecting metabolic abnormalities in neurofibromatosis type 1 that are not revealed in brain parenchyma of normal appearance?
    Rodrigues AC, Ferraz-Filho JR, Torres US, da Rocha AJ, Muniz MP, Souza AS, Goloni-Bertollo EM, Pavarino ÉC.
    Pediatr Neurol; 2015 Mar 23; 52(3):314-9. PubMed ID: 25585912
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.